著作(論文等)

基本情報

氏名 末永 敦
氏名(カナ) スエナガ アツシ
氏名(英語) SUENAGA Atsushi
所属 山陽小野田市立山口東京理科大学工学部数理情報科学科
職名 教授
researchmap研究者コード
researchmap機関

発表形態

掲載年月

2026/10/12

掲載誌名等

npj Drug Discovery

論文名

Benchmarking Boltz-2 for relative kinase-inhibitor interaction patterns across conformational states and resistance mutations

著者名

Atsushi Suenaga & Noriaki Okimoto

巻

3

号

開始頁

46

 

終了頁

出版者(日本語)

出版者(英語)

Springer Nature

概要

Generative structure-prediction models can directly predict protein-ligand complexes from sequence and ligand information, but their ability to capture pharmacologically relevant kinase-inhibitor interactions remains incompletely understood. We systematically evaluated Boltz-2 using curated biochemical IC50 measurements across eight human kinases, nine clinically used inhibitors, and representative resistance mutations. Although predicted log10(IC50) values showed a compressed dynamic range relative to experimental measurements, mutation-dependent shifts in inhibitor sensitivity, inhibitor selectivity patterns, and overall potency rankings showed substantial agreement with the experimental patterns within the present benchmark. Predicted binding probability showed good discrimination between binder and non-binder pairs within the present benchmark and a consistent inverse relationship with experimental potency. Structural analyses showed that ligand-pose variability was associated with prediction behavior within the evaluated kinase-inhibitor systems, even when kinase-domain structures showed close agreement with the corresponding experimental structures. Larger ligand RMSD values were not associated with larger prediction errors in magnitude, but were linked to systematic shifts in prediction bias, indicating that ligand-pose accuracy and predictive utility are not equivalent measures of Boltz-2 performance. These findings suggest that, within the present benchmark, relative kinase-inhibitor interaction patterns were reproduced more consistently than absolute potency values. We provide a framework for interpreting Boltz-2 outputs within the kinase-inhibitor systems examined here.